Bellwether Advisors LLC acquired a new stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor acquired 5,797 shares of the biotechnology company’s stock, valued at approximately $2,449,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its holdings in Axon Enterprise by 122,993.6% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 461,601 shares of the biotechnology company’s stock worth $195,036,000 after purchasing an additional 461,226 shares during the period. B. Metzler seel. Sohn & Co. AG acquired a new stake in shares of Axon Enterprise during the second quarter worth $3,854,000. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Axon Enterprise during the first quarter worth $15,067,000. Brown Lisle Cummings Inc. raised its holdings in shares of Axon Enterprise by 97,231.4% during the second quarter. Brown Lisle Cummings Inc. now owns 34,066 shares of the biotechnology company’s stock worth $19,098,000 after purchasing an additional 34,031 shares during the period. Finally, State Street Corp lifted its position in shares of Axon Enterprise by 5,700.2% in the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after buying an additional 209,879,882 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Activity
In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of the business’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the transaction, the insider directly owned 56,264 shares of the company’s stock, valued at $27,032,038.80. The trade was a 1.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the completion of the transaction, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 37,397 shares of company stock valued at $21,234,034. Company insiders own 4.20% of the company’s stock.
Analyst Ratings Changes
View Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Stock Performance
AXON stock traded up $8.32 during mid-day trading on Friday, reaching $315.43. The company had a trading volume of 1,273,041 shares, compared to its average volume of 1,583,639. Axon Enterprise, Inc has a one year low of $291.45 and a one year high of $665.07. The stock has a market capitalization of $25.69 billion, a P/E ratio of 101.10, a P/E/G ratio of 5.84 and a beta of 1.48. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. The stock’s 50-day simple moving average is $417.79 and its two-hundred day simple moving average is $467.68.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The firm had revenue of $908.55 million for the quarter, compared to the consensus estimate of $934.33 million. During the same quarter in the prior year, the company posted $1.17 EPS. The firm’s revenue was up 27.8% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc will post 2.10 EPS for the current year.
Axon Enterprise Company Profile
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
Further Reading
- Five stocks we like better than Axon Enterprise
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
- 3 GARP Plays That Could Offer a Better Balance as Markets Turn Volatile
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
